Tadamitsu Kishimoto
- Immunology top 0.01%
- T-cell and B-cell Immunology 137
- Immune Cell Function and Interaction 129
- Immune Response and Inflammation 53
- Immunodeficiency and Autoimmune Disorders 50
- Immunotherapy and Immune Responses 39
- Oncology top 0.01%
- Cytokine Signaling Pathways and Interactions 178
- Hematology top 0.02%
- Rheumatology top 0.02%
- Immunology and Allergy top 0.05%
-
- Monoclonal and Polyclonal Antibodies Research 101
-
- NF-κB Signaling Pathways 38
- Co-authors
- Tetsuya TagaShizuo AkiraMasashi NarazakiToshio HiranoToshio TanakaAkihiro KimuraNorihiro NishimotoKazuyuki Yoshizaki
- Cited by
- ImmunologyOncologyHematology
- Journals
- The Journal of Immunology (85 papers)Proceedings of the National Academy of Sciences (46 papers)The Journal of Experimental Medicine (20 papers)
- Partner nations
- JapanUnited StatesFrance
In The Last Decade
Tadamitsu Kishimoto
634 papers receiving 75.2k citations
Hit Papers
Peers
Comparison fields: 5 of 183
- Immunology 34.0k
- Oncology 25.7k
- Hematology 8.8k
- Rheumatology 8.2k
- Immunology and Allergy 2.9k
Countries citing papers authored by Tadamitsu Kishimoto
This map shows the geographic impact of Tadamitsu Kishimoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tadamitsu Kishimoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tadamitsu Kishimoto more than expected).
Fields of papers citing papers by Tadamitsu Kishimoto
This network shows the impact of papers produced by Tadamitsu Kishimoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tadamitsu Kishimoto. The network helps show where Tadamitsu Kishimoto may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Tadamitsu Kishimoto, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 5 | |
| 2 | 2024 | 10 | |
| 3 | 2024 | 2 | |
| 4 | 2024 | 7 | |
| 5 | 2021 | 21 | |
| 6 | 2021 | 31 | |
| 7 | Translating IL-6 biology into effective treatmentsbreakdown → | 2020 | 441 |
| 8 | 2020 | 35 | |
| 9 | 2020 | 245 | |
| 10 | 2019 | 25 | |
| 11 | 2018 | 8 | |
| 12 | 2017 | 37 | |
| 13 | 2017 | 37 | |
| 14 | 2017 | 11 | |
| 15 | 2013 | 173 | |
| 16 | 2010 | 14 | |
| 17 | 2009 | 57 | |
| 18 | 2008 | 429 | |
| 19 | 2003 | 257 | |
| 20 | The analysis of peripheral blood lymphocytes of patients with silicosis and effects of silica in vitro | 1996 | 2 |
About Tadamitsu Kishimoto
Tadamitsu Kishimoto is a scholar working on Immunology, Oncology and Hematology, having authored 643 papers that have together received 77.6k indexed citations. Recurring topics across this work include Cytokine Signaling Pathways and Interactions (178 papers), T-cell and B-cell Immunology (137 papers), Immune Cell Function and Interaction (129 papers), Monoclonal and Polyclonal Antibodies Research (101 papers), Immune Response and Inflammation (53 papers), Immunodeficiency and Autoimmune Disorders (50 papers), Immunotherapy and Immune Responses (39 papers) and NF-κB Signaling Pathways (38 papers). The work is most often cited by research in Immunology (34.0k citations), Oncology (25.7k citations) and Hematology (8.8k citations). Tadamitsu Kishimoto has collaborated with scholars based in Japan, United States and France. Frequent co-authors include Tetsuya Taga, Shizuo Akira, Masashi Narazaki, Toshio Hirano, Toshio Tanaka, Akihiro Kimura, Norihiro Nishimoto, Kazuyuki Yoshizaki, Tetsuji Naka and Hitoshi Kikutani. Their work appears in journals such as The Journal of Immunology, Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine, Blood and International Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.